Timothy Noyes
Chief Executive Officer presso AEROVATE THERAPEUTICS, INC.
Profilo
Timothy P.
Noyes is currently the Chief Executive Officer & Director at Aerovate Therapeutics, Inc. Prior to his current position, he served as the President, Chief Executive Officer & Director at Proteon Therapeutics, Inc. from 2006 to 2020 and at Arcuate Therapeutics, Inc. from 2019 to 2021.
He also held the position of Director at Iconix Biosciences, Inc. and Director at Protara Therapeutics, Inc. from 2006 to 2019.
Additionally, Mr. Noyes worked as the President at GelTex Pharmaceuticals, Inc. from 1996 to 2002 and as the Chief Operating Officer at Essential Therapeutics, Inc. He was also the President-Renal Division at Genzyme Corp.
from 2001 to 2002 and the Chief Operating Officer at Trine Pharmaceuticals, Inc. from 2002 to 2006.
Mr. Noyes obtained an MBA from Harvard Business School and completed his undergraduate studies at Harvard College.
Posizioni attive di Timothy Noyes
Società | Posizione | Inizio |
---|---|---|
AEROVATE THERAPEUTICS, INC. | Chief Executive Officer | 01/02/2021 |
Precedenti posizioni note di Timothy Noyes
Società | Posizione | Fine |
---|---|---|
Arcuate Therapeutics, Inc.
Arcuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcuate Therapeutics, Inc. engages in the pharmaceutical industry. The company is headquartered in Boston, MA. | Chief Executive Officer | 01/02/2021 |
PROTARA THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2020 |
PROTARA THERAPEUTICS, INC. | Chief Executive Officer | 01/11/2017 |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Chief Operating Officer | 03/09/2008 |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Chief Operating Officer | 01/03/2006 |
Formazione di Timothy Noyes
Harvard Business School | Masters Business Admin |
Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
AEROVATE THERAPEUTICS, INC. | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Aziende private | 7 |
---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Iconix Biosciences, Inc.
Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | Health Technology |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
Arcuate Therapeutics, Inc.
Arcuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcuate Therapeutics, Inc. engages in the pharmaceutical industry. The company is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Timothy Noyes